Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CERT - Certara, Inc.


11.73
0.110   0.938%

Share volume: 1,389,083
Last Updated: 03-07-2025
Computer Software/Services – Computer Programming And Data Processing: 0.00%

PREVIOUS CLOSE
CHG
CHG%

$11.62
0.11
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
27%
Profitability 0%
Dept financing 23%
Liquidity 75%
Performance 43%
Company vs Stock growth
vs
Performance
5 Days
0.95%
1 Month
-15.37%
3 Months
3.17%
6 Months
6.83%
1 Year
-38.33%
2 Year
-42.27%
Key data
Stock price
$11.73
P/E Ratio 
0.00
DAY RANGE
$11.13 - $11.95
EPS 
-$0.08
52 WEEK RANGE
$9.41 - $19.29
52 WEEK CHANGE
-$37.74
MARKET CAP 
1.714 B
YIELD 
N/A
SHARES OUTSTANDING 
160.889 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.43
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,501,757
AVERAGE 30 VOLUME 
$1,418,358
Company detail
CEO: William F. Feehery
Region: US
Website: certara.com
Employees: 350
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Computer Software/Services – Computer Programming And Data Processing
Sector: Services

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. The company also provides related technology- enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

Recent news